PETER BLANCKAERT
Show
Sort by
-
Improved targeting with F(ab)2 fragments of monoclonal antibody 14C5 for imaging and therapy of metastatic disease
-
Synthese van de precursor, radiosynthese en in vivo evaluatie in muizen van [123I]-(4-fluorofenyl){1-[2-(4-iodofenyl)ethyl]piperidin-4-yl}methanon, als potentiële SPECT ligand voor de 5-HT2A-receptor
-
In vitro evaluatie van 14C5 monoklonaal antilichaamderivaten voor gebruik in radioimmunodiagnostiek en radioimmunotherapie
-
Targeting properties of radiolabelled monoclonal antibody 14c5 directed against a cell substrate adhesion molecule
-
123I-labelled monoclonal antibody 14C5 for SPECT tumour imaging: In vivo evaluation of athymic mice bearing a LoVo tumour
-
Synthesis, radiosynthesis and preliminary in vivo evaluation of [123I]-(1-(5-iodo-2-methoxyphenethyl)piperidin-4-yl)(4-fluorophenyl)methanone as a potential SPECT tracer for visualizing the 5-HT2A-receptor
-
Internalization and cellular processing of radiolabeled monoclonal antibody 14C5
-
Synthesis and preliminary in vivo evaluation of [18F] labelled derivatives of Org 13063 as potential PET radioligands for the 5-HT1A receptor
-
Precursor synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(2-iodophenyl)ethyl]piperidin-4-yl}-methanone and -methanol, as potential SPECT tracers for the 5-HT2A-receptor
-
Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging